LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2017

Jun 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2017-06-01

Reporting Person: Hall James G (Executive Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-01	Incentive Stock Option (Right to Buy)	$14	M	75000	Acquired	2024-06-01	Common Stock (75000)	Direct
2017-06-01	Right to Buy Restricted Stock Unit (RSU)	$	M	25000	Acquired		Common Stock (25000)	Direct

Footnotes

F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.

F2: 1/36 of the grant becomes exercisable on each monthly anniversary of the grant date, June 1, 2017.

F3: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock subject to vesting at a rate of 1 share per unit.